Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Clinical management of woman with bleeding disorders: A survey among European haemophilia treatment centres

KPM. van Galen, M. Lavin, N. Skouw-Rasmussen, E. Ivanova, E. Mauser-Bunschoten, M. Punt, G. Romana, P. Elfvinge, R. D'Oiron, R. Abdul-Kadir

. 2020 ; 26 (4) : 657-662. [pub] 20200527

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21020397

Grant support
European Association for Haemophilia and Allied Disorders

INTRODUCTION: The impact of bleeding for women with bleeding disorders (WBD) is of increasing focus and importance. Despite this, optimal management strategies are unclear and knowledge gaps persist. AIM: To examine practices and define research priorities on diagnosis and management of WBD in Europe. METHODS: An electronic survey on clinical management of WBD was sent to 136 European haemophilia treatment centres (HTCs), including open questions on knowledge gaps and research priorities. RESULTS: Fifty-nine HTCs from 12 Western (WE) and 13 Central/Eastern European (CEE) countries completed the survey. Less than half runs a joint clinic (24 HTCs, 42%). Most centres without a joint clinic have a named obstetrician (81%) and/or gynaecologist (75%) available for collaboration. Overall 18/54 (33%) European HTCs do not offer preimplantation genetic diagnosis. Third trimester amniocentesis to guide obstetric management is available 28/54 HTCs (52%), less frequent in CEE compared to WE countries (5/17 vs 23/37, P = .03). 53% of HTCs (28/53) reported that only 0%-25% of WBD seek medical advice for heavy menstrual bleeding (HMB). An algorithm managing acute HMB in WBD is lacking in 22/53 (42%) HTCs. The main reported knowledge and research gaps are lack of awareness & education on WBD among patients and caregivers, optimal diagnostic strategies and effective multidisciplinary management of pregnancy & HMB. CONCLUSION: Joint clinics, prenatal diagnostics and algorithms for managing acute HMB are lacking in many European HTCs. HMB may be an underestimated issue. This survey highlights the need to prioritize improvement of knowledge and patient care for WBD across Europe.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020397
003      
CZ-PrNML
005      
20210830102113.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/hae.14043 $2 doi
035    __
$a (PubMed)32459044
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a van Galen, Karin P M $u Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
245    10
$a Clinical management of woman with bleeding disorders: A survey among European haemophilia treatment centres / $c KPM. van Galen, M. Lavin, N. Skouw-Rasmussen, E. Ivanova, E. Mauser-Bunschoten, M. Punt, G. Romana, P. Elfvinge, R. D'Oiron, R. Abdul-Kadir
520    9_
$a INTRODUCTION: The impact of bleeding for women with bleeding disorders (WBD) is of increasing focus and importance. Despite this, optimal management strategies are unclear and knowledge gaps persist. AIM: To examine practices and define research priorities on diagnosis and management of WBD in Europe. METHODS: An electronic survey on clinical management of WBD was sent to 136 European haemophilia treatment centres (HTCs), including open questions on knowledge gaps and research priorities. RESULTS: Fifty-nine HTCs from 12 Western (WE) and 13 Central/Eastern European (CEE) countries completed the survey. Less than half runs a joint clinic (24 HTCs, 42%). Most centres without a joint clinic have a named obstetrician (81%) and/or gynaecologist (75%) available for collaboration. Overall 18/54 (33%) European HTCs do not offer preimplantation genetic diagnosis. Third trimester amniocentesis to guide obstetric management is available 28/54 HTCs (52%), less frequent in CEE compared to WE countries (5/17 vs 23/37, P = .03). 53% of HTCs (28/53) reported that only 0%-25% of WBD seek medical advice for heavy menstrual bleeding (HMB). An algorithm managing acute HMB in WBD is lacking in 22/53 (42%) HTCs. The main reported knowledge and research gaps are lack of awareness & education on WBD among patients and caregivers, optimal diagnostic strategies and effective multidisciplinary management of pregnancy & HMB. CONCLUSION: Joint clinics, prenatal diagnostics and algorithms for managing acute HMB are lacking in many European HTCs. HMB may be an underestimated issue. This survey highlights the need to prioritize improvement of knowledge and patient care for WBD across Europe.
650    _2
$a algoritmy $7 D000465
650    _2
$a amniocentéza $x statistika a číselné údaje $7 D000649
650    _2
$a koagulopatie $x komplikace $x diagnóza $x farmakoterapie $x epidemiologie $7 D001778
650    _2
$a poradenství $7 D003376
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zdraví - znalosti, postoje, praxe $7 D007722
650    _2
$a hemofilie A $x komplikace $x diagnóza $x farmakoterapie $7 D006467
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a silné menstruační krvácení $x diagnóza $x etiologie $x terapie $7 D008595
650    _2
$a poporodní krvácení $x epidemiologie $x etiologie $7 D006473
650    _2
$a těhotenství $7 D011247
650    _2
$a hematologické komplikace těhotenství $x epidemiologie $7 D011250
650    _2
$a třetí trimestr těhotenství $7 D011263
650    _2
$a preimplantační diagnóza $x statistika a číselné údaje $7 D019836
650    _2
$a prenatální diagnóza $x normy $7 D011296
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a von Willebrandova nemoc $x komplikace $x diagnóza $x farmakoterapie $7 D014842
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lavin, Michelle $u Irish Centre for Vascular Biology, School of Pharmacy and Biomedical Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland $u Department of Haematology, Beaumont Hospital, Beaumont, Dublin, Ireland
700    1_
$a Skouw-Rasmussen, Naja $u European Haemophilia Consortium, Brussels, Belgium
700    1_
$a Ivanova, Eva $u Department of Haematology, University Hospital, Hradec Králové, Czech Republic
700    1_
$a Mauser-Bunschoten, Eveline $u Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
700    1_
$a Punt, Marieke $u Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
700    1_
$a Romana, Gerychová $u Department of Gynaecology, University Hospital Brno, Brno, Czech Republic
700    1_
$a Elfvinge, Petra $u Department of Haematology, Karolinska University, Stockholm, Sweden
700    1_
$a D'Oiron, Roseline $u Inserm U 1176, APHP Paris Saclay, Hôpital Bicêtre, Le Kremlin Bicêtre, France
700    1_
$a Abdul-Kadir, Rezan $u Department of Obstetrics and Gynaecology, Royal Free Foundation Hospital and Institute for Women's Health, University College London, London, UK
773    0_
$w MED00001964 $t Haemophilia : the official journal of the World Federation of Hemophilia $x 1365-2516 $g Roč. 26, č. 4 (2020), s. 657-662
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32459044 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102113 $b ABA008
999    __
$a ok $b bmc $g 1691050 $s 1140843
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 26 $c 4 $d 657-662 $e 20200527 $i 1365-2516 $m Haemophilia $n Haemophilia (Oxf., Print) $x MED00001964
GRA    __
$p European Association for Haemophilia and Allied Disorders
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options